Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W H Clark

Showing results (141-150 of 175) with videos related to

Pageof 18
Sort By:
Seminars in Oncology|June 1, 1975
The developmental biology of primary human malignant melanomasW H Clark, A M Ainsworth, E A Bernardino, et al.
Journal of the American Academy of Dermatology|April 1, 1987
Hereditary melanoma and the dysplastic nevus syndrome: the risk of cancers other than melanomaM H Greene, M A Tucker, W H Clark, et al.
Annals of Internal Medicine|April 1, 1985
High risk of malignant melanoma in melanoma-prone families with dysplastic neviM H Greene, W H Clark, M A Tucker, et al.
Journal of the American Academy of Dermatology|April 1, 1986
How well do physicians recognize melanoma and other problem lesions?B R Cassileth, W H Clark, E J Lusk, et al.
The Journal of Pediatrics|July 1, 1983
Dysplastic nevi on the scalp of prepubertal children from melanoma-prone familiesM A Tucker, M H Greene, W H Clark, et al.
Cancer|March 1, 1979
Multiple primary melanomaH S Moseley, A E Giuliano, F K Storm, et al.
Cancer Investigation|January 1, 1983
Production and characterization of monoclonal antibodies against human malignant melanomaM Herlyn, Z Steplewski, D Herlyn, et al.
Archives of Dermatology|February 1, 1989
Reduced DNA repair in cultured melanocytes and nevus cells from a patient with xeroderma pigmentosumK H Kraemer, M Herlyn, S H Yuspa, et al.
Journal of the National Cancer Institute|March 15, 1989
Inhibition of metastases of a human melanoma xenograft by monoclonal antibody to the GD2/GD3 gangliosidesD Iliopoulos, C Ernst, Z Steplewski, et al.
Lancet (London, England)|January 21, 1984
Managing the dysplastic naevus syndromeM H Greene, W H Clark, M A Tucker, et al.
Pageof 18

Showing results (141-150 of 175) with videos related to

Sort By:
Pageof 18
Seminars in Oncology|June 1, 1975
The developmental biology of primary human malignant melanomasW H Clark, A M Ainsworth, E A Bernardino, et al.
Journal of the American Academy of Dermatology|April 1, 1987
Hereditary melanoma and the dysplastic nevus syndrome: the risk of cancers other than melanomaM H Greene, M A Tucker, W H Clark, et al.
Annals of Internal Medicine|April 1, 1985
High risk of malignant melanoma in melanoma-prone families with dysplastic neviM H Greene, W H Clark, M A Tucker, et al.
Journal of the American Academy of Dermatology|April 1, 1986
How well do physicians recognize melanoma and other problem lesions?B R Cassileth, W H Clark, E J Lusk, et al.
The Journal of Pediatrics|July 1, 1983
Dysplastic nevi on the scalp of prepubertal children from melanoma-prone familiesM A Tucker, M H Greene, W H Clark, et al.
Cancer|March 1, 1979
Multiple primary melanomaH S Moseley, A E Giuliano, F K Storm, et al.
Cancer Investigation|January 1, 1983
Production and characterization of monoclonal antibodies against human malignant melanomaM Herlyn, Z Steplewski, D Herlyn, et al.
Archives of Dermatology|February 1, 1989
Reduced DNA repair in cultured melanocytes and nevus cells from a patient with xeroderma pigmentosumK H Kraemer, M Herlyn, S H Yuspa, et al.
Journal of the National Cancer Institute|March 15, 1989
Inhibition of metastases of a human melanoma xenograft by monoclonal antibody to the GD2/GD3 gangliosidesD Iliopoulos, C Ernst, Z Steplewski, et al.
Lancet (London, England)|January 21, 1984
Managing the dysplastic naevus syndromeM H Greene, W H Clark, M A Tucker, et al.
Pageof 18